Patents Assigned to Applied Pharmaceutical Science, Inc.
  • Publication number: 20170355666
    Abstract: The present invention relates to polymorphic forms of the compound of Formula I (i.e., ethyl 2-cyano-3,12-dioxokana-1,9(11)-dien-28-oate (CDDO ethyl ester)) and methods of using them for treating a variety of disease states such as cancer and conditions associated with inflammation.
    Type: Application
    Filed: May 22, 2017
    Publication date: December 14, 2017
    Applicants: Applied Pharmaceutical Science Inc.
    Inventors: Xiaohong Zhang, Lu Song, Wendong Sun, Kaiyang Liu, Chunlei Han
  • Patent number: 9656951
    Abstract: The present invention relates to polymorphic forms of the compound of Formula I (i.e., ethyl 2-cyano-3,12-dioxoIeana-1,9(11)-dien-28-oate (CDDO ethyl ester)) and methods of using them for treating a variety of disease states such as cancer and condisitons associated with inflammation.
    Type: Grant
    Filed: December 6, 2012
    Date of Patent: May 23, 2017
    Assignee: Applied Pharmaceutical Science, Inc.
    Inventors: Xiaohong Zhang, Lu Song, Wendong Sun, Kaiyang Liu, Chunlei Han